Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors

Pediatric Hematology and Oncology

Volumn 22, Issue 3, 2005, Pages 189-198

  Casanova, Michela ^a   Massimino, Maura ^a   Ferrari, Andrea ^a   Spreafico, Filippo ^a   Piva, Luigi ^a   Coppa, Jorgelina ^a   Luksch, Roberto ^a   Cefalo, Graziella ^a   Terenziani, Monica ^a   Polastri, Daniela ^a   Bellani, Franca Fossati ^a   Mazzaferro, Vincenzo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Chemotherapy; Cis platin; Epirubicin; Etoposide; Hepatoblastoma; Hepatocellular carcinoma

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEBRILE NEUTROPENIA; FEMALE; HEPATOBLASTOMA; HUMAN; INFANT; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; NEUTROPENIA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; CISPLATIN; EPIRUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; MALE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20944448885     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010590921441     Document Type: Article

References (14)

1. Fossati-Bellani F, Massimino M. Liver tumors in childhood: epidemiology and clinics. J Surg Oncol. 1993;suppl 3:119-121.
2. Darbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology. 2003;38:560-566.
3. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusuion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000;18:2665-2675.
4. Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach-results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol. 2000;18:3819-3828.
5. Fuchs J, Rydzynski J, von Schweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma. Cancer. 2002;95:172-182.
6. Evans AE, Land VJ, Newton WA, et al. Combination chemotherapy (vincristine, adriamycin, cyclophoshamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer. 1982;50:821-826.
7. Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group inter-group study. J Clin Oncol. 2002;20:2789-2797.
8. Czauderna P, Mackinlay G, Perilongo G, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol. 2002;20:2798-2804.
9. National Cancer Institute. NCI common toxicity criteria, version 1. In Investigator's Handbook: A Manual of Participants in Clinical Trials of Investigational Agents. Sponsored by the Division of Cancer Treatment, National Cancer Institute, Bethesda, MD, U.S. Department of Health and Human Services, Public Health service, National Institutes of Health; October 1993.
10. Katzenstein HM, Rigsby C, Shaw PH, et al. Novel therapeutic approaches in the treatment of children with hepatoblastoma. J Pediatr Hematol Oncol. 2002;24:751-755.
11. Warmann SW, Fuchs J, Wilkens L, et al. Succesful therapy of subcutaneously growing human hepatoblastoma xenografts with topotecan. Med Pediatr Oncol. 2001;37:449-454.
12. Fuchs J, Habild G, Leuschner I, et al. Paclitaxel: an effective antineoplastic agent in the treatment of xenotransplanted hepatoblastoma. Med Pediatr Oncol. 1999;32:209-215.
13. Fuchs J, Wenderoth M, von Schweinitz D, et al. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. Cancer. 1998;83:2400-2407.
14. Katzenstein HM, London WB, Douglass EC, et al. Treatment of unresectable and metastatic hepatoblastoma: a Pediatric Oncology Group phase II study. J Clin Oncol. 2002;20:3438-3444.